✦ LIBER ✦

The oral DPP-4 inhibitor linagliptin significantly lowers HbA1c after 4 weeks of treatment in patients with type 2 diabetes mellitus

✍ Scribed by T. Forst; B. Uhlig-Laske; A. Ring; A. Ritzhaupt; U. Graefe-Mody; K. A. Dugi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Twelve weeks treatment with the DPP-4 in

✍ K. Aaboe; F. K. Knop; T. Vilsbøll; C. F. Deacon; J. J. Holst; S. Madsbad; T. Kra 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 838 KB

Efficacy and safety of the dipeptidyl pe

✍ I. Raz; M. Hanefeld; L. Xu; C. Caria; D. Williams-Herman; H. Khatami; Sitaglipti 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 160 KB

Efficacy and safety of the dipeptidyl pe

✍ K. Hermansen; M. Kipnes; E. Luo; D. Fanurik; H. Khatami; P. Stein; Sitagliptin S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB